Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Late potentials assessment - an useful tool for Brugada Syndrome risk stratification

View through CrossRef
Abstract Funding Acknowledgements Type of funding sources: None. Introduction Brugada syndrome (BrS) is a channelopathy confining an increased risk of sudden cardiac death (SCD). Asymptomatic patients (pts) management remains challenging enhancing the necessity for additionally stratification tools. Purpose To evaluate the role of the non-invasive assessment of late potentials (LP) based on SA-ECG as stratification tools in a BrS cohort. Methods Prospective, observational single-center study of pts with BrS with the following criteria (1) Type 1 Brugada ECG pattern, either spontaneous or drug induced; (2) SA-ECG performed before anti-arrhythmic treatment; (3) minimum follow up duration of 12 months. LPs were evaluated by SA-ECG with determination of the total filtered QRS duration (fQRS); root mean square voltage of the 40ms terminal portion of the QRS (RMS40) and duration of the low amplitude electric potential component of the terminal portion of the QRS (LAS40) in conventional and modified right precordial leads. Malignant arrhythmic events (MAEs) were defined as a composite event of SCD or appropriate ICD shocks. Association of relevant risk factors and MAE was conducted with Univariate Cox regression analysis, as well as SA-ECG evaluated as a continuous and categorical divided on standard cut-offs (fQRS >114ms, RMS40<20µV, LAS40>38ms). A risk score for predicting MAE was computed incorporating the significant LPs variables. Results A total of 106 pts fulfilled the inclusion criteria (mean age: 48 ± 12 years, 67.9% male), 52 (49.1%) with type 1 spontaneous pattern. The majority were asymptomatic at baseline (81.1%) while 13 presented with syncope and 3 with polymorphic VT/cardiac arrest. A total of 10 (7.1%) pts MAEs were documented during a mean 4.7 years - 4 with SCD and 6 with appropriate ICD shocks. Clinical presentation with a polymorphic VT/cardiac arrest (p <0.001) and LP evaluated on SA-ECG were significant predictors of MAE on univariate analysis, except for RMS40 on conventional leads. Neither of the common risk factors (male gender, spontaneous type 1 pattern at baseline, previous syncope or the presence of a pathogenic SCN5A mutation) were predictors of MAE during follow-up– figure 1. Positive LPs defined by standard cut-offs, in all variables and leads, were significantly associated with an increased risk of MAE during follow-up – figure 2. A LP score was computed incorporating the standard cut-offs on conventional leads. The presence of 2 and 3 positive LP represented an additionally 4.7-fold increased risk of MAE during follow-up (HR 4.693, 95% CI 1.506-14.624, p = 0.008) – figure 2. Conclusion LPs based on noninvasive assessment SAECG represent an useful prognostic stratification tool in BrS. A LP score based on standard cut-offs identified a subset of pts at a higher risk of events and who may deserve individualized preventive strategies.
Title: Late potentials assessment - an useful tool for Brugada Syndrome risk stratification
Description:
Abstract Funding Acknowledgements Type of funding sources: None.
Introduction Brugada syndrome (BrS) is a channelopathy confining an increased risk of sudden cardiac death (SCD).
Asymptomatic patients (pts) management remains challenging enhancing the necessity for additionally stratification tools.
Purpose To evaluate the role of the non-invasive assessment of late potentials (LP) based on SA-ECG as stratification tools in a BrS cohort.
Methods Prospective, observational single-center study of pts with BrS with the following criteria (1) Type 1 Brugada ECG pattern, either spontaneous or drug induced; (2) SA-ECG performed before anti-arrhythmic treatment; (3) minimum follow up duration of 12 months.
LPs were evaluated by SA-ECG with determination of the total filtered QRS duration (fQRS); root mean square voltage of the 40ms terminal portion of the QRS (RMS40) and duration of the low amplitude electric potential component of the terminal portion of the QRS (LAS40) in conventional and modified right precordial leads.
Malignant arrhythmic events (MAEs) were defined as a composite event of SCD or appropriate ICD shocks.
Association of relevant risk factors and MAE was conducted with Univariate Cox regression analysis, as well as SA-ECG evaluated as a continuous and categorical divided on standard cut-offs (fQRS >114ms, RMS40<20µV, LAS40>38ms).
A risk score for predicting MAE was computed incorporating the significant LPs variables.
Results A total of 106 pts fulfilled the inclusion criteria (mean age: 48 ± 12 years, 67.
9% male), 52 (49.
1%) with type 1 spontaneous pattern.
The majority were asymptomatic at baseline (81.
1%) while 13 presented with syncope and 3 with polymorphic VT/cardiac arrest.
A total of 10 (7.
1%) pts MAEs were documented during a mean 4.
7 years - 4 with SCD and 6 with appropriate ICD shocks.
Clinical presentation with a polymorphic VT/cardiac arrest (p <0.
001) and LP evaluated on SA-ECG were significant predictors of MAE on univariate analysis, except for RMS40 on conventional leads.
Neither of the common risk factors (male gender, spontaneous type 1 pattern at baseline, previous syncope or the presence of a pathogenic SCN5A mutation) were predictors of MAE during follow-up– figure 1.
Positive LPs defined by standard cut-offs, in all variables and leads, were significantly associated with an increased risk of MAE during follow-up – figure 2.
A LP score was computed incorporating the standard cut-offs on conventional leads.
The presence of 2 and 3 positive LP represented an additionally 4.
7-fold increased risk of MAE during follow-up (HR 4.
693, 95% CI 1.
506-14.
624, p = 0.
008) – figure 2.
Conclusion LPs based on noninvasive assessment SAECG represent an useful prognostic stratification tool in BrS.
A LP score based on standard cut-offs identified a subset of pts at a higher risk of events and who may deserve individualized preventive strategies.

Related Results

Positive Brugada Challenge Test in V1R–V3R as a Predictor of Malignant Prognosis in Brugada Patients
Positive Brugada Challenge Test in V1R–V3R as a Predictor of Malignant Prognosis in Brugada Patients
BackgroundThe Brugada syndrome is a heterogeneous genetic disease that predisposes to life‐threatening ventricular tachyarrhythmias and sudden cardiac death (SCD). The only proven ...
Low-dose oral flecainide provocation test for Brugada syndrome: a case series
Low-dose oral flecainide provocation test for Brugada syndrome: a case series
Abstract Background Brugada syndrome is a rare, inherited cardiac disorder that predisposes individuals to life-threatening ventricular arrhythmi...
Optimising tool wear and workpiece condition monitoring via cyber-physical systems for smart manufacturing
Optimising tool wear and workpiece condition monitoring via cyber-physical systems for smart manufacturing
Smart manufacturing has been developed since the introduction of Industry 4.0. It consists of resource sharing and networking, predictive engineering, and material and data analyti...
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Abstract Thoracic outlet syndrome (TOS) is a complex and often overlooked condition caused by the compression of neurovascular structures as they pass through the thoracic outlet. ...
Three in One: Systemic Lupus Erythematosus, HELLP Syndrome, and Antiphospholipid Syndrome: A Case Report and Literature Review
Three in One: Systemic Lupus Erythematosus, HELLP Syndrome, and Antiphospholipid Syndrome: A Case Report and Literature Review
Abstract Introduction Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease commonly affecting women of reproductive age. Its overlap with HELLP syndrome (Hemolysi...
e0568 Followup of five patients with Brugada syndrome treated with ICD
e0568 Followup of five patients with Brugada syndrome treated with ICD
Objective To investigate clinical symptoms, episodes of arrhythmias and its therapy in patients with Brugada syndrome treated with implantable cardioverter-defibr...
Risk Stratification and Therapeutic Approach in Brugada Syndrome
Risk Stratification and Therapeutic Approach in Brugada Syndrome
Brugada syndrome (BrS) is a clinical entity characterised by an incomplete right bundle branch block associated with an ST segment elevation in the right precordial leads and a ris...

Back to Top